Singapore Medical Group has its heart set on regional growth
The group aims to strengthen its foothold abroad, albeit with cautious optimism, especially in Australia, Vietnam and Indonesia.
OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.
Even as it continues to grow its domestic business across the Republic's heartlands, the Catalist-listed company is hungry for further expansion and new ventures in the Asia-Pacific.
"We're one of the few Singapore healthcare companies that have been actively investing and growing our overseas footprint. From that standpoint, we're extremely unique," says Beng Teck Liang, SMG's chief executive officer and executive director.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Prudential shutters Hong Kong wealth unit Pulse
Singapore has to be realistic on global trends plaguing its stock market: DPM Wong
Google DeepMind unveils next generation of drug discovery AI model
AEM Holdings Q1 net profit tumbles 85% to S$2.4 million
World’s biggest tea buyer Lipton’s sale of last farms is a strategy shift
JPMorgan, Nomura limit Segantii exposure on Hong Kong case